Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y1VZ
|
|||
| Former ID |
DCL000322
|
|||
| Drug Name |
GT-389255
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Discontinued in Phase 2 | [1] | |
| Company |
Peptimmune
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lipase unspecific (LIP) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011891) | |||
| REF 2 | Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006 Apr;7(4):312-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.